NeoGenomics signals $797M-$803M 2026 revenue outlook following PanTracer Liquid MolDX approval
NeoGenomics, Inc. · SERVICES-TESTING LABORATORIES · Now $10.44
+3.3% in 1d after detection
Post-detection moves
1h
—
1d
+3.3%
3d
+0.4%
7d
0.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS